BOCAIR is established as Australia and New Zealand’s exclusive manufacturer of BOCA Air Sanitiser products. 

BOCAIR recognised that there is an absolute need for a solution that effectively eliminates the increase of harmful pathogens present in the air. 

The increase of COVID-19 and other seasonal viruses have raised major concerns amongst health care professionals and Government bodies regarding the transmission of harmful airborne pathogens. Such pathogens are easily contracted by individuals and are said to lead to serious health complications. 

Extensive research and investigation stated that both products - BOCAIR, and BOCA Air Sanitiser, are the ultimate solution to eliminating the risk of contracting harmful viruses and bacteria contaminating the air around us. 

BOCA™ Technology

Extensive research by a medical product development company was conducted prior to the development of BOCA Air Sanitiser to ensure accuracy and reliability. This product development company has produced up to 14 registered patents and several since have been granted. 

Patents for the key technologies utilised during the in the air sanitiser process have been filed in Australia as Patent Pending. 

The technology utilised in the development of BOCA Air Sanitiser involves a unique process that assists in deactivating harmful pathogens present around us, rendering them as inactive. This unique process is possible due to the scientific discoveries on electrolysis and ionisation of water molecules.

Developed using lightweight portable USB powered units, the size of BOCA Air Sanitiser caters to both small and large spaces to best suit all customer preference and needs. Further, the product's free standing feature allows customers to utilise BOCA Air Sanitiser in various academic health, business and age-care settings.